Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis
Year: 2021
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Molecular Psychiatry
Institutions: SUNY Upstate Medical University, Icahn School of Medicine at Mount Sinai, Oxford Health NHS Foundation Trust, Warneford Hospital, University of Oxford, University of Zurich, Heidelberg University, ETH Zurich, Central Institute of Mental Health, Medizinische Fakultät Mannheim, Psychiatrische Universitätsklinik Zürich, University of Nottingham, Solent NHS Trust, NYU Langone Health, University of Southampton, New York University
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Genetic Predictors, Transcriptomic Biomarkers, & Neurobiological Signatures of Resilience to Alzheimer's Disease, Choosing the right antidepressant for depressive disorder, 3/7 Psychiatric Genomics Consortium: Finding actionable variation, Discoveries in ADHD genomics: Help or hype in clinical settings?, G849790392, SLE Treatment with N-acetylcysteine
OpenAlex ID: W3160809396
